Page 65 - Read Online

Page 10 of 10 Yamaguchi et al. Hepatoma Res 2018;4:50 I http://dx.doi.org/10.20517/2394-5079.2018.68

hepatocellular carcinoma. Int J Clin Exp Pathol 2015;8:3404-9.
56. Shi M, Guo RP, Lin XJ, Zhang YQ, Chen MS, Zhang CQ, Lau WY, Li JQ. Partial hepatectomy with wide versus narrow resection
margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 2007;245:36-43.
57. Poon RT, Ng IO, Fan ST, Lai EC, Lo CM, Liu CL, Wong J. Clinicopathologic features of long-term survivors and disease-free survivors
after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol 2001;19:3037-44.
58. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Takayama T, Kawasaki S,
Makuuchi M. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J
Hepatol 2003;38:200-7.
59. Yang LY, Fang F, Ou DP, Wu W, Zeng ZJ, Wu F. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma
with good outcome after hepatic resection. Ann Surg 2009;249:118-23.
60. Franco D, Capussotti L, Smadja C, Bouzari H, Meakins J, Kemeny F, Grange D, Dellepiane M. Resection of hepatocellular carcinomas.
Results in 72 European patients with cirrhosis. Gastroenterology 1990;98:733-8.
61. Ishizuka M, Kubota K, Kita J, Shimoda M, Kato M, Sawada T. Impact of an inflammation-based prognostic system on patients
undergoing surgery for hepatocellular carcinoma: a retrospective study of 398 Japanese patients. Am J Surg 2012;203:101-6.
62. Mano Y, Shirabe K, Yamashita Y, Harimoto N, Tsujita E, Takeishi K, Aishima S, Ikegami T, Yoshizumi T, Yamanaka T, Maehara Y.
Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective
analysis. Ann Surg 2013;258:301-5.
63. Voron T, Tselikas L, Pietrasz D, Pigneur F, Laurent A, Compagnon P, Salloum C, Luciani A, Azoulay D. Sarcopenia impacts on short-
and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg 2015;261:1173-83.
64. Utsunomiya T, Shimada M, Kudo M, Ichida T Matsui O, Izumi N, Matsuyama Y, Sakamoto M, Nakashima O, Ku Y, Takayama T,
Kokudo N; Liver Cancer Study Group of Japan. A comparison of the surgical outcomes among patients with HBV-positive, HCV-
positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11950 patients. Ann Surg 2015;261:513-20.
65. Garancini M, Nespoli S, Romano F, Uggeri F, Degrate L, Okolicsanyi S, Gianotti L. Surgical management of hepatocellular carcinoma
within and beyond BCLC indications in a middle volume center. J Visc Surg 2018;17:S1878-86.
66. Wu F, Wang L, Wu J, Rong W, Tian F, Bi C. Analysis of risk factors of recurrence in patients with BCLC 0-A hepatocellular carcinoma
after surgical resection. Zhonghua Yi Xue Za Zhi 2015;95:1747-50.
67. Jiang L, Yan L, Wen T, Li B, Zeng Y, Yang J, Wang W, Xu M, Wu H. Comparison of outcomes of hepatic resection and radiofrequency
ablation for hepatocellular carcinoma patients with multifocal tumors meeting the Barcelona-Clinic Liver Cancer stage A classification.
J Am Coll Surg 2015;221:951-61.
68. Li J, Huang L, Liu CF, Cao J, Yan JJ, Xu F, Wu MC, Yan YQ. Risk factors and surgical outcomes for spontaneous rupture of BCLC
stages A and B hepatocellular carcinoma: a case-control study. World J Gastoenterol 2014;20:9121-7.
69. Xu W, Guo R, Xu G, Sun L, Hu D, Xu H, Yang H, Sang X, Lu X, Mao Y. Management of intrahepatic recurrence after resection for
hepatocellular carcinoma exceeding the barcelona clinic liver cancer criteria. Oncotarget 2017;8:110406-14.
70. Wang K, Eguchi S, Hidaka M, Jin T, Soyama A, Kuroki T, Huang M, Wu L, Zou S, Shao J. Comparison of the outcomes of
hepatocellular carcinoma after hepatectomy between two regional medical centers in China and Japan. Asian J Surg 2017;40:380-8.
71. Shrager B, Jibara Ga, Tabrizian P, Schwartz ME, Labow DM, Hiotis S. Resection of large hepatocellular carcinoma (≥10 cm): a unique
western perspective. J Surg Oncol 2013;107:111-7.
72. Lee SG, Hwang S, Jung JP, Lee YJ, Kim KH, Ahn CS. Outcome of patients with huge hepatocellular carcinoma after primary resection
and treatment of recurrent lesions. Br J Surg 2007;94:320-6.
73. Shah SA, Wei AC, Cleary SP, Yang I, Gilvray ID, Gallinger S, Grant DR, Greig PD. Prognosis and results after resection of very large
(>or=10 cm) hepatocellular carcinoma. J Gastrointest Surg 2007;11:589-95.
74. Pandey D, Lee KH, Wai CT, Wagholikar G, Tan KC. Long term outcome and prognostic factors for large hepatocellular carcinoma (10
cm or more) after surgical resection. Ann Surg Oncol 2007;14:2817-23.
75. Ng KK, Vauthey JN, Pawlik TM, Lauwers GY, Regimbeau JM, Belghiti J, Ikai I, Yamaoka Y, Curley SA, Nagorney DM, Ng IO, Fan
ST, Poon RT; International Cooperative Study Group on Hepatocellular Carcinoma. Is hepatic resection for large or multinodular
hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol 2005;12:364-73.
76. Roayaie S, Jivara G, Taouli B, Schwartz M. Resection of hepatocellular carcinoma with macroscopic vascular invasion. Ann Surg Oncol
2013;20:3754-60.
77. Ban D, Shimada K, Yamamoto Y, Nara S, Esaki M, Sakamoto Y, Kosuge T. Efficacy of a hepatectomy and a tumor thrombectomy for
hepatocellular carcinoma with tumor thrombus extending to the main portal vein. J Gastrointest Surg 2009;13:1921-8.
78. Vitale A, Saracino E, Boccagni P, Brolese A, D’Amico F, Gringeri E, Neri D, Srsen N, Valmasoni M, Zanus G, Carraro A, Violi P,
Pauletto A, Bassi D, Polacco M, Burra P, Farinati F, Feltracco P, Romano A, D’Amico DF, Cillo U. Validation of the BCLC prognostic
system in surgical hepatocellular cancer patients. Transplant Proc 2009;41:1260-3.